$KMFG
KEEMO Fashion Group Ltd

2024 Q4 Form 10-K Financial Statement

#000149315224040685 Filed on October 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024
Revenue $4.946K $21.52K
YoY Change -24.09% 27.01%
Cost Of Revenue $2.438K $10.94K
YoY Change -28.4% 27.25%
Gross Profit $2.508K $10.59K
YoY Change -19.38% 26.76%
Gross Profit Margin 50.71% 49.19%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$8.401K -$42.28K
YoY Change -67.52% 89.97%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$8.401K -$42.28K
YoY Change -67.52% 90.46%
Income Tax
% Of Pretax Income
Net Earnings -$8.401K -$42.28K
YoY Change -67.52% 90.46%
Net Earnings / Revenue -169.85% -196.43%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 55.00M shares 55.00M shares
Diluted Shares Outstanding 55.00M shares 55.00M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $18.14K $19.42K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $5.170K $2.527K
Prepaid Expenses $3.059K $6.526K
Receivables
Other Receivables
Total Short-Term Assets $26.37K $28.47K
YoY Change 43.48% -33.84%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $26.37K $28.47K
Total Long-Term Assets $0.00 $0.00
Total Assets $26.37K $28.47K
YoY Change 43.48% -33.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $80.52K $69.92K
YoY Change 73.05%
Accrued Expenses $3.200K $7.500K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.72K $77.42K
YoY Change 64.42% 55.76%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $83.72K $77.42K
Total Long-Term Liabilities
Total Liabilities $83.72K $77.42K
YoY Change 64.42% 55.76%
SHAREHOLDERS EQUITY
Retained Earnings -$89.45K -$81.05K
YoY Change 38.38% 109.04%
Common Stock $5.500K $5.500K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$57.35K -$48.95K
YoY Change
Total Liabilities & Shareholders Equity $26.37K $28.47K
YoY Change 43.48% -33.84%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024
OPERATING ACTIVITIES
Net Income -$8.401K -$42.28K
YoY Change -67.52% 90.46%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.280K -$9.322K
YoY Change -94.82% -47.74%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$1.280K -$9.322K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -$1.280K -$9.322K
YoY Change -94.82% -187.42%
FREE CASH FLOW
Cash From Operating Activities -$1.280K -$9.322K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-22196 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
8594 usd
CY2024 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure
CY2023 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001935033
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q3 KFGL Prepaid Stock Registrar Fees
PrepaidStockRegistrarFees
usd
CY2024Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2024Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
usd
CY2023Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
usd
CY2024 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
CY2023 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
CY2024 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
CY2023 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-07-31
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2024 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55000000 shares
CY2024Q3 KFGL No Insider Trading Flag
NoInsiderTradingFlag
true
CY2024 dei Auditor Name
AuditorName
JP CENTURION & PARTNERS PLT
CY2024 dei Auditor Firm
AuditorFirmId
6723
CY2024 dei Auditor Location
AuditorLocation
Kuala Lumpur, Malaysia
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19421 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28743 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6954 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2527 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3405 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6526 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3933 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
28474 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
43035 usd
CY2024Q3 us-gaap Assets
Assets
28474 usd
CY2023Q3 us-gaap Assets
Assets
43035 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
69919 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
40405 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7500 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9300 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
77419 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
49705 usd
CY2024Q3 us-gaap Liabilities
Liabilities
77419 usd
CY2023Q3 us-gaap Liabilities
Liabilities
49705 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55000000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
5500 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5500 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26600 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26600 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81045 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38770 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-48945 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6670 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28474 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43035 usd
CY2024Q3 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
ten-for-one
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21522 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16945 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
10936 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
8594 usd
CY2024 us-gaap Gross Profit
GrossProfit
10586 usd
CY2023 us-gaap Gross Profit
GrossProfit
8351 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52861 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30605 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-42275 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-22254 usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
58 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42275 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22196 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-42275 usd
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-42275 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22196 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55000000 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55000000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40486413 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40486413 shares
CY2024Q3 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
ten-for-one
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-12974 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
28500 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-22196 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6670 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6670 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-42275 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-48945 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-48945 usd
CY2024Q3 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
ten-for-one
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-42275 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-22196 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6954 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6954 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-878 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
901 usd
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2593 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3933 usd
CY2024 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
29514 usd
CY2023 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
14647 usd
CY2024 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1800 usd
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1500 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9322 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17837 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28500 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28500 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9322 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10663 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28743 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18080 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19421 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28743 usd
CY2024Q3 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
ten-for-one
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-42275 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9322 usd
CY2024Q3 KFGL Working Capital
WorkingCapital
48945 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-48945 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zcZupPPsuswh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zieQoSnc5Fhg">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management uses estimates and assumptions in preparing these financial statements in accordance with US GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities in the balance sheets, and the reported revenue and expenses during the periods reported. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2527 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3405 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2527 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3405 usd
CY2024Q3 KFGL Prepaid Stock Registrar Fees
PrepaidStockRegistrarFees
4690 usd
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1836 usd
CY2023Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
3933 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6526 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3933 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
69919 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
40405 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
69919 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7500 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9300 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7500 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9300 usd
CY2022Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
3600000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
3600 usd
CY2024Q3 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
ten-for-one
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-42275 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-22196 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-42275 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22196 usd
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
42275 usd
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The NOL carry forwards begin to expire in 2043
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8878 usd
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
8878 usd
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
8142 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8878 usd
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8142 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8878 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21522 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16945 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21522 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16945 usd
CY2024 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure
CY2023 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1 pure
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6954 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
10936 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
8594 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
10936 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21522 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
10936 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52861 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-42275 usd
CY2024Q3 us-gaap Assets
Assets
28474 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16945 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
8594 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30605 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-22254 usd
CY2023Q3 us-gaap Assets
Assets
43035 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21522 usd
CY2024 us-gaap Cost Of Revenue
CostOfRevenue
10936 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52861 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-42275 usd
CY2024Q3 us-gaap Assets
Assets
28474 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16945 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
8594 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30605 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-22254 usd
CY2023Q3 us-gaap Assets
Assets
43035 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-42275 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9322 usd
CY2024Q3 KFGL Working Capital
WorkingCapital
48945 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-48945 usd
CY2024Q3 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
ten-for-one
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001

Files In Submission

Name View Source Status
0001493152-24-040685-index-headers.html Edgar Link pending
0001493152-24-040685-index.html Edgar Link pending
0001493152-24-040685.txt Edgar Link pending
0001493152-24-040685-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_001.jpg Edgar Link pending
kfgl-20240731.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
kfgl-20240731_cal.xml Edgar Link unprocessable
kfgl-20240731_lab.xml Edgar Link unprocessable
kfgl-20240731_pre.xml Edgar Link unprocessable
kfgl-20240731_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending